Calamos Advisors
TELA icon

Calamos Advisors’s TELA Bio TELA Stock Holding History

Calamos Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,776
Closed -$192K – 996
2024
Q1 		$192K Sell
33,776
-2,194
-6% -$14.5K ﹤0.01% 774
2023
Q4 		$238K Sell
35,970
-28,615
-44% -$165K ﹤0.01% 746
2023
Q3 		$517K Sell
64,585
-18,469
-22% -$172K ﹤0.01% 712
2023
Q2 		$841K Buy
83,054
+66,214
+393% +$677K ﹤0.01% 721
2023
Q1 		$179K Buy
16,840
+6,512
+63% +$71.8K ﹤0.01% 884
2022
Q4 		$119K Sell
10,328
-40,792
-80% -$365K ﹤0.01% 963
2022
Q3 		$436K Buy
+51,120
New +$424K ﹤0.01% 1022

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Calamos Advisors's TELA Position: Q2 2024 in Review

Calamos Advisors sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 33,776 shares — an estimated $192K sold.

Calamos Advisors first reported a position in TELA in Q3 2022 and held it in 7 quarters. The position peaked at $841K in Q2 2023. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

  • Calamos Advisors reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
  • Calamos Advisors sold 33,776 TELA Bio shares in Q2 2024, an estimated $192K.
  • Calamos Advisors first reported a position in TELA Bio in Q3 2022 and held it in 7 quarters.
  • Calamos Advisors's TELA Bio position peaked at $841K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on Calamos Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.